HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amniotic membrane transplantation for treatment of symblepharon in a patient with recessive dystrophic epidermolysis bullosa.

AbstractPURPOSE:
To report the surgical treatment of a case with epidermolysis bullosa.
METHODS:
A 12-year-old girl with dystrophic epidermolysis bullosa presented to our clinic with a symblepharon connecting the lateral half of the left upper lid to the upper temporal quadrant of the cornea. The central cornea exhibited diffuse opacity and vascularization.
RESULTS:
During surgery, the symblepharon was lysed, and lamellar keratectomy was performed. The operated portion of cornea and palpebral conjunctiva was covered with amniotic membrane to promote healing. Fourteen months later, the operated eyelid margin was normal and the eye was fully mobile. The temporal portion of the corneal stroma was still thinner than normal and showed mild superficial vascularization and opacification.
CONCLUSION:
We believe that amniotic membrane transplantation is a valuable way to treat symblepharon in cases of epidermolysis bullosa.
AuthorsRana Altan-Yaycioglu, Yonca A Akova, Sibel Oto
JournalCornea (Cornea) Vol. 25 Issue 8 Pg. 971-3 (Sep 2006) ISSN: 0277-3740 [Print] United States
PMID17102678 (Publication Type: Case Reports, Journal Article)
Topics
  • Amnion (transplantation)
  • Child
  • Epidermolysis Bullosa Dystrophica (complications)
  • Eyelid Diseases (etiology, surgery)
  • Female
  • Humans
  • Tissue Adhesions (etiology, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: